8 research outputs found
Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)
Get PDFNew discriminant score to predict the fibrotic stage of non-alcoholic steatohepatitis in Japan
Get PDF
A pilot study of triple therapy with telaprevir 1500 mg, peginterferon and ribavirin for elderly HCV patients
No full textSafety and efficacy of lenvatinib in Child-Pugh A and B patients with unresectable hepatocellular carcinoma in clinical practice
No full textEndothelial Robo4 regulates IL-6 production by endothelial cells and monocytes via a crosstalk mechanism in inflammation
No full textWhat Is the Most Effective Drug Delivery System for Cisplatin during the Treatment of Hepatic Tumors with Single-Session Transcatheter Chemotherapy? A Pilot Study
No full textGenome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer
No full textPrevious genome-wide association studies have identified risk loci for pancreatic cancer but were centered on individuals of European ancestry. Here the authors identify GP2 gene variants associated with pancreatic cancer susceptibility in populations of East Asian ancestry
